Scientific Publications

Search by Keyword(s)
Found 9 results

Filters: Author is Dranoff, G  [Clear All Filters]

Search Results

  • Showing 1-9 of 9 Results
2016
The Human Vaccines Project: A roadmap for cancer vaccine development.Romero, P., Banchereau J., Bhardwaj N., Cockett M., Disis ML, Dranoff G., Gilboa E., Hammond SA, Hershberg R., Korman AJ, Kvistborg P., Melief C., Mellman I., Palucka AK, Redchenko I., Robins H., Sallusto F., Schenkelberg T., Schoenberger S., Sosman J., et al. Science translational medicine, 2016/04/13, Volume 8, Issue 334, p.334ps9, (2016) Read More / View Supplemental Materials
Abstract
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.Koyama, S., Akbay EA, Li YY, Herter-Sprie GS, Buczkowski KA, Richards W. G., Gandhi L., Redig AJ, Rodig SJ, Asahina H., Jones RE, Kulkarni MM, Kuraguchi M., Palakurthi S., Fecci PE, Johnson B. E., Janne PA, Engelman JA, Gangadharan SP, Costa DB, et al. Nature communications, 2016/02/17, Volume 7, p.10501, (2016) Read More / View Supplemental Materials
Abstract
2015
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Mima, K., Nishihara R., Qian ZR, Cao Y., Sukawa Y., Nowak JA, Yang J., Dou R., Masugi Y., Song M., Kostic AD, Giannakis M., Bullman S., Milner DA, Baba H., Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G., Garrett WS, et al. Gut, 2015/08/26, (2015) Read More / View Supplemental Materials
Abstract
2014
Vaccines and Melanoma.Ott, PA, Fritsch EF, Wu CJ, and Dranoff G. Hematology/oncology clinics of North America, 2014/06/01, Volume 28, Issue 3, p.559-569, (2014) Read More / View Supplemental Materials
Abstract
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression.Xu, C., Fillmore CM, Koyama S., Wu H., Zhao Y., Chen Z., Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A., Reibel JB, Walton Z., Ji H., Watanabe H., Jänne PA, Castrillon DH, Rustgi AK, Bass AJ, Freeman GJ, Padera RF, et al. Cancer cell, 2014/05/12, Volume 25, Issue 5, p.590-604, (2014) Read More / View Supplemental Materials
Abstract
In vivo discovery of immunotherapy targets in the tumour microenvironment.Zhou, P., Shaffer DR, Alvarez Arias DA, Nakazaki Y., Pos W., Torres AJ, Cremasco V., Dougan SK, Cowley GS, Elpek K., Brogdon J., Lamb J., Turley SJ, Ploegh HL, Root DE, Love JC, Dranoff G., Hacohen N., Cantor H., and Wucherpfennig KW Nature, 2014/02/06, Volume 506, Issue 7486, p.52-7, (2014) Read More / View Supplemental Materials
Abstract
2013
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.Akbay, EA, Koyama S., Carretero J., Altabef A., Tchaicha JH, Christensen CL, Mikse OR, Cherniack AD, Beauchamp EM, Pugh TJ, Wilkerson MD, Fecci PE, Butaney M., Reibel JB, Soucheray M., Cohoon TJ, Janne PA, Meyerson M., Hayes DN, Shapiro GI, et al. Cancer discovery, 2013/09/27, (2013) Read More / View Supplemental Materials
Abstract
2008
Modeling genomic diversity and tumor dependency in malignant melanoma.Lin, WM, Baker AC, Beroukhim R., Winckler W., Feng W., Marmion JM, Laine E., Greulich H., Tseng H., Gates C., Hodi FS, Dranoff G., Sellers WR, Thomas RK, Meyerson M., Golub T. R., Dummer R., Herlyn M., Getz G., and Garraway LA Cancer research, 2008/02/01, Volume 68, Issue 3, p.664-73, (2008) Read More / View Supplemental Materials
Abstract
2007
High-throughput oncogene mutation profiling in human cancer.Thomas, RK, Baker AC, Debiasi RM, Winckler W., LaFramboise T., Lin WM, Wang M., Feng W., Zander T., MacConaill L., Lee JC, Nicoletti R., Hatton C., Goyette M., Girard L., Majmudar K., Ziaugra L., Wong KK, Gabriel S., Beroukhim R., et al. Nature genetics, 2007/03/01, Volume 39, Issue 3, p.347-51, (2007) Read More / View Supplemental Materials
Abstract
  • Showing 1-9 of 9 Results